Notwithstanding, we are not quite sure how CBS fraction (αCBSF) ameliorates β-amyloid pathology and cognitive functioning in 5XFAD and tau pathology in 3xTg-AD mouse model. This evidence concerns the gene MAPT and Alzheimer disease.